Diagnostics & Testing

Olink, part of Thermo Fisher Scientific, delivers next-generation proteomics platforms based on proprietary PEA technology and NGS readouts, enabling high-throughput, highly specific protein biomarker analysis from small sample volumes. Its discovery-scale and targeted panels, together with the Olink Insight bioinformatics app, support pharma, biobank, and academic teams across major disease areas from biomarker discovery to precision medicine.

Olink, part of Thermo Fisher Scientific, provides high-throughput, affinity-based proteomics platforms and assays based on Proximity Extension Assay (PEA) technology for protein biomarker analysis from small sample volumes. Its Explore series, targeted panels and Olink Insight bioinformatics app support discovery-to-translation biomarker and proteogenomics research across major disease areas, and the company is headquartered in Uppsala, Sweden.

Omega Bio-tek is a private biotechnology company specializing in DNA and RNA purification kits and reagents for research and genomics laboratories. Its E.Z.N.A.® and Mag-Bind® product lines cover genomic DNA, RNA, cfDNA, plasmid, FFPE, and NGS workflows, with strong support for automation and high-throughput use. Extensive protocols, application notes, and cross-reference tools support procurement and technical teams.

OncoHost is a precision oncology diagnostics company built around its PROphet® proteomics and AI platform. The PROphetNSCLC® blood test predicts clinical benefit from PD-1/PD-L1 immunotherapy in advanced NSCLC, providing composite biomarker decision-support for first-line treatment selection and supporting oncology care and pharma research.

Opentrons Labworks Inc is a private biotechnology and lab automation company that provides flexible, AI-enabled liquid-handling robots, software, and application workstations for NGS, PCR, proteomics, and nucleic acid extraction. Its open, modular ecosystem combines no-code tools, a Python API, and an extensive protocol library to help labs automate repetitive workflows while maintaining control over assays, instruments, and AI tools.

Oxford Nanopore Technologies plc develops nanopore-based DNA and RNA sequencing platforms, from portable devices like MinION to high-throughput systems, supported by library preparation kits and analysis workflows such as EPI2ME. Its research-use solutions enable real-time, short-to-ultra-long read sequencing and targeted panels, including the Oxford Nanopore Hereditary Cancer Panel, for genomics, microbiology, oncology and broader life science applications.

PHC Holdings Corporation is a Tokyo-based public healthcare group that leads PHC Group, offering diabetes management, life-science instruments, diagnostics, clinical testing, CRO services, and healthcare IT solutions in over 120 countries. Its subsidiaries provide ultra-low freezers, CO2 incubators, CGT tools, pathology systems, POCT devices, and digital health platforms that support pharma and biotech R&D, clinical trials, and routine care.

PacBio is a public sequencing company specializing in long-read and HiFi sequencing for research and clinical research applications. Its flagship Revio platform, plus consumables, prep kits, and software, support genome, transcriptome, epigenome, and microbiome workflows.

Panome Bio is a St. Louis–based multi-omics CRO offering next-generation metabolomics, discovery proteomics, transcriptomics and integrated multi-omics services for biomarker discovery and mechanistic insight. Using advanced LC/MS and proprietary tools like its MassID engine, it delivers untargeted, high-depth metabolomics and proteomics data plus integrated analyses and curated reports for pharma, biotech and research customers.

Parse Biosciences, a QIAGEN company, provides instrument‑free Evercode single cell sequencing kits, services and software for whole transcriptome, immune profiling, CRISPR screens and FFPE samples at scales up to millions of cells. Its portfolio, including Trailmaker analysis and GigaLab services, is designed for pharma and translational researchers needing high‑throughput, flexible single cell solutions that integrate with existing sequencing infrastructure.

PBD Biotech is a diagnostics company developing proprietary phage-based assays and qPCR kits for rapid detection of tuberculosis and other mycobacterial infections from blood. Its lead technology, Actiphage, is designed to identify live mycobacteria and people at risk of TB progression, supported by patents and clinical trials. The company targets clinical, public health and research users seeking advanced TB diagnostic tools.

PerkinElmer is a global science and technology company providing diagnostics, analytical instruments, software-automation, and specialized biopharma services across biopharma, applied, and food markets. With platforms such as ONESOURCE, Project Farma, Covaris, and Perten, plus a strong ESG and sustainable procurement focus, it supports pharma R&D and manufacturing globally.

Personalis is a precision oncology diagnostics company providing ultrasensitive MRD testing and comprehensive tumor profiling from its CLIA-certified, CAP-accredited genomics lab in Fremont, California. Its NeXT-based platform supports early cancer recurrence detection, therapy selection, and biomarker-driven drug development for healthcare providers and biopharma partners.

Plasmidsaurus is a sequencing-as-a-service provider offering ultrafast, high-accuracy DNA and RNA sequencing for plasmids, RNA-Seq, amplicons, whole genomes, AAV and microbiome samples. With global labs and dropboxes, integrated bioinformatics and simple online ordering, it helps pharma, biotech and diagnostics teams validate constructs, profile gene expression and characterize microbial or vector samples without in-house sequencing infrastructure.

PlaqueTec is a Cambridge-based medtech company developing precision medicine solutions for coronary artery disease through its proprietary Liquid Biopsy System platform, enabling biomarker discovery and disease endotyping for pharmaceutical R&D.

Alamar Biosciences offers a fully automated Precision Proteomics Platform that combines NULISA technology with the ARGO instrument for ultra-high sensitivity, multiplex protein biomarker analysis from very small sample volumes. With ready-to-use inflammation and CNS panels, custom assay tools, and sample analysis services, it supports biomarker discovery and translational research in pharma and biotech. The company is headquartered in Fremont, California.

Primerdesign is a UK-based molecular diagnostics company specialising in qPCR assays, kits and reagents for human healthcare, food, water, agriculture and veterinary applications. It delivers ready-to-deploy, open-platform assays, custom assay development, OEM-ready qPCR kits and integrated sample-to-result workflows, supported by experienced teams and dedicated application support.

Promega Corporation is a privately owned biotechnology company headquartered in Madison, Wisconsin, supplying over 4,000 products for genomics, protein analysis, cellular analysis, drug discovery and human identification. It provides assays, reagents and instruments along with technical support to enable small molecule drug discovery, cell and gene therapy workflows, clinical diagnostics and forensic DNA analysis for customers worldwide.

ProteomEdge is a Swedish proteomics company providing multiplex panels of isotope‑labelled protein standards for absolute protein quantification in plasma using mass spectrometry. Its qRePS™-based portfolio, including ApoEdge™, DiscoveryEdge™175/600, ComplemEdge and LiverEdge, targets clinically relevant biomarkers across apolipoproteins, complement, inflammation and liver disease. The products support scalable, high-precision plasma proteomics for research and translational applications.

ProtonDx is a UK-based diagnostics company offering rapid, portable molecular testing platforms, proprietary nucleic acid extraction kits and bespoke research solutions for Research Use Only applications. Its portfolio spans human and animal health, life sciences and other molecular diagnostics fields, with a focus on multi‑pathogen, point‑of‑need testing.

Pure Lab Water For Science (ELGA LabWater) supplies pure and ultrapure lab water systems for scientific, analytical, and clinical applications. The brand combines hardware solutions spanning RO-grade to Type I ultrapure water with selection tools, case studies, guides, and USA events to help labs validate performance and choose the right system.

Q2 Solutions is now IQVIA Laboratories, a global clinical trial laboratory services provider offering central lab, biomarker, genomics, bioanalytical, vaccine, and digital workflow services for pharmaceutical and biotech clinical trials.

Qlucore is a precision medicine software and diagnostics company offering visualization‑based multi‑omics analysis tools and IVDR‑certified leukemia diagnostics. Its Omics Explorer, Insights and Diagnostics products support proteomics, qPCR, NGS, biomarker discovery, disease subtyping and RNA‑seq‑based pediatric leukemia testing for research and clinical teams.

Quantabio is a private life science reagents company based in Beverly, Massachusetts, specializing in advanced DNA/RNA amplification reagents, qPCR/RT‑qPCR ToughMixes and sparQ NGS library prep solutions for Illumina platforms. Its portfolio targets difficult samples, high‑throughput PCR and cost‑efficient sequencing, with a growing emphasis on eco‑friendly lyophilized formats such as eQo 1‑Step ToughMix.